Phrenic nerve paralysis due to vincristine

Leukemia and Lymphoma

Volumn 48, Issue 12, 2007, Pages 2452-2453

  Gilliland, Paul ^a   Holguin, Mark ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FUROSEMIDE; ITRACONAZOLE; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; AUTONOMIC NEUROPATHY; B CELL LYMPHOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONSTIPATION; DYSPHAGIA; GLUCOSE BLOOD LEVEL; HISTORY OF MEDICINE; HUMAN; HYPERURICEMIA; LARGE CELL LYMPHOMA; MALE; MYALGIA; NERVE PARALYSIS; NEUROTOXICITY; PARESTHESIA; PHRENIC NERVE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MALE; PARALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; PHRENIC NERVE; VINCRISTINE;

EID: 37149007015     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701671077     Document Type: Article

References (13)

1. Staton, G. W. and Ingram, R. H. (2004) Disorders of the chest wall. ACP Medicine 2004, 2, WebMD Inc., New York, NY
2. Imai, T. and Matsumato, H. (2006) Insidious phrenic nerve involvement in postpolio syndrome. Intern Med, 45, pp. 563-564.
3. Janda, A. (1981) Neurological complications secondary to subclavian venipuncture. Anesthesist, 30, pp. 148-149.
4. Rumbak, M. J., Chokshi, S. K., Abel, N., Abel, W., Kittusamy, P. K. and McCormack, J. (1996) Left phrenic nerve paresis complicating catheter radiofrequency ablation for Wolff - Parkinson - White syndrome. Am Heart J, 132, pp. 1281-1285.
5. Koscielniak-Nielson, Z. J. (2000) Hemidiaphragmatic paresis after interscalene supplementation of insufficient axillary block with 3 ml of 2% mepivacaine. Acta Anaesthesiol Scand, 44, pp. 1160-1162.
6. Wheeler, W. E., Rubis, L. J., Jones, C. W. and Harrah, J. D. (1985) Etiology and prevention of topical cardiac hypothermia-induced phrenic nerve injury and left lower lobe atelectasis during cardiac surgery. Chest, 88, pp. 680-683.
7. Rice, A. L., Ullal, J. and Vinik, A. I. (2007) Reversal of phrenic nerve palsy with topiramate. Diabetes Complications, 21, pp. 63-67.
8. Legha, S. S. (1986) Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol, 1, pp. 421-427.
9. Toker, E., Yenice, D. and Ogut, M. S. (2004) Isolated abducens nerve palsy induced by vincristine therpy. J AAPOS, 8, pp. 69-71.
10. Rezvani, K., Bain, B. J. and Coulter, C. A. (1998) Loss of singing ability caused by vincristine. Clin Lab Haematol, 20, pp. 47-48.
11. Quasthoff, S. and Hartung, H. P. (2002) Chemotherapy-induced peripheral neuropathy. J Neurol, 249, pp. 9-17.
12. Bermudez, M., Fuster, J. L., Linares, E., Galera, A. and Gonzalez, C. (2005) Intraconazole-related increased vincristine neurotoxicity: Case report and review of literature. J Pediatr Hematol Oncol, 27, pp. 389-392.
13. Naumann, R., Mohm, J., Reuner, U., Kroschinsky, F., Rautenstrauss, B. and Ehninger, G. (2001) Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity. Br J Haematol, 115, pp. 323-325.